Szemészet, 2015 (152. évfolyam, 1-4. szám)

2015-03-01 / 1. szám

Retinal nerve thickness layer evaluation after different I Irodalom 1. Boldt HC, Munden PM, Folk JC, Mehaffey MG. Visual field defects after macular hole surgery. Am J Ophthalmol 1996; 122: 371-381. 2. Ebisawa N, Mori K, Yoneya S. Thickness of retinal nerve fibre layer decreases after vitreous surgery for idiopathic macular hole. Jpn J Ophthalmol 2000; 104: 142-147. 3. Ejstrup R, la Cour M, Heegaard S, Kiilgaard JF Toxicity profiles of subretinal indocyanine green, Brilliant Blue G, and triamcinolone acetonide: a comparative study. Graafes Arch Clin Ophthalmol 2012; 250: 6B9-677. 4. Farah ME, Maia M, Rodrigues EB. Dyes in ocular surgery: principles for use in chromovitrectomy. Am J Ophthalmol 2009; 148: 332-340. 5. Ferencz M, Somfai GM, Farkas A, et a I. Functional assessment of the possible toxicity of indocyanine qreen dye in macular hole surqery. Am J Ophthalmol 2006; 142 (5): 765-70. 6. Gass CA, Haritoglou C, Schaumberger M, Kampik A. Functional outcome of macular hole surgery with and without indocyanine green-assisted peeling of the internal limiting membrane. Graafe's Arch Clin Exp Ophthalmol 2003; 241: 716-720. 7. Hibi N, Kondo M, Ishikawa K, et a I. Transient increase of retinal nerve fiber layer thickness after macular hole surgery. Int Ophthalmol 2014; 34 (3): 575-81. 8. Hutton WL, Fuller DG, Snyder WB, et a I. Visual field defects after macular hole surgery: a new finding. Ophthalmol 1996; 103: 2152-2158. 9. Kelly NE, Wendel RT. Vitreous surgery for idiopathic macular holes. Results of a pilot study. Arch Ophthalmol 1991; 109: 654-659. 10. Kiilgaard JF, Nissen MH, la Cour M. An isotonic preparation of 1 mg/ml indocyanine green is not toxic to hyperconfluent ARPE19 cells, even after prolonged exposure. Acta Ophthalmol Scand 2006; 84: 42-46. 11. Kim KY, Yu SY, Kim MS, Kim ES, Kwak HW. Changes of parafoveal retinal nerve fiber layer thickness analyzed by spectral-domain optical coherence tomo­graphy after pars plana vitrectomy. Retina 2013; 33 (4): 776-84. 12. McCannel CA, Ensminger JL, Diehl NN, Hodge DN. Population based incidence of macular holes. Ophthalmology 2009; 116: 1366-1369. 13. Narayanan R, Mungeal JK, Kenney MC, et al. Toxicity of triamcinolone acetonide on retinal neurosensory and pigment epithel cells. Invest Ophthalmol Vis Sei 2006; 47: 722-728. 14. Nomoto H, Shiraga F Yamaji H, et al. Macular hole surgery with tramcinolone acetonide-assisted internal limiting membrane peeling: one-year results. Retina 2008; 28: 427-432. 15. Papp A, Pregun T, Szabó A, et al. Intravitreális triamcinolon-acetonid a diffúz di­abeteses macula-oedema kezelésében. Szemészet 2007; 144 [11: 21-26. 16. Rodrigues EB, Meyer CH, Kroll P Chromovitrectomy: a new field in vitreoretinal surgery. Graafes Arch Clin Exp Ophthalmol 2005; 243: 291-293. 17. Ruiz-Moreno JM, Montero JA, Bayon A, et al. Retinal toxicity of intravitreal triamcinolone acetonide at high doses in the rabbit. Exp Eye Res 2007; 84 342-348. 18. Shah GK, Rosenblatt BJ, Blinder KJ, et al. Triamcinolone-assisted internal limit­ing membrane peeling. Retina 2005; 25: 972-975. 19. Spiteri Cornish K, Lois N, Scott N, et al. Vitrectomy with internal limiting membrane (ILM) peeling versus vitrectomy with no peeling for idiopathic full­thickness macular hole (FTMH). Cochrane Database Syst Rev 2013 Jun 5; 6: CD009306. 20. Stanescu-Segall D, Jackson TL. Vital staining with indocyanine green: a review of the clinical and experimental studies relating to safety. Eye 2009: 23: 504-518. 21. Steel DWH, Lotery AJ. Idiopathic vitreomacular traction and macular hole: a comprehensive review of pathophysiology, diagnosis, and treatment. Eye 2013; 27: S1-S21. 22. Tóba Y, Machida S, Kurosaka D. Comparisons of retinal nerve fiber layer thickness after indocyanine green, brilliant blue G, or triamcinolone acetonide­­assisted macuar hole surgery. J Ophthalmol 2014; 2014: 187308. 23. Tuzson R, Varsányi В, Vince Nagy B, et al. Role of multifocal electroretinography in the diagnosis of idiopathic macular hole. Invest Ophthalmol Vis Sei 2010; 51 (31:1666-70. 24. von Jagow B, Höing A, Gandorfer A, et al. Functional outcome of indocyanine green-assisted macular surgery. Retina 2009; 29: 1249-56. 25. Yamashita T, Uemura A. Kita H, Sakamoto T. Analysis of the retinal nerve fiber layer after indocyanine green-assisted vitrectomy for idiopathic macular holes. Ophthalmology 2006; 113: 280-284. Levelezési cí Dn Lukács Regina, 1Q85 Budapest, Mária u. 39. E-mail: Iukacs.regina85@gmail.com TROPHOSAN Visiobalance Időskori makuladegenerációs betegek étrendjének kiegészítésére Forgalmazó: Dr. Kocsis & Hoffmann Pharma Kft. 1024 Budapest, Retek utca 32.; Tel.: +361 438 0257; e-mail: drkh@drkh.hu; Gyártó: Protina Pharm. GmbH 85737 Ismaning, Adalperostrasse 37. Németország OÉT1 nyilvántartási száma: 1739/2013. www.trophosan.hu Kapható a gyógyszertárakban és a fitotékákban. Speciális - gyógyászati célra szánt - tápszer A TROPHOSAN Visiobalance kapható havi ill. 3 havi kiszerelésben. A napi 2x2, azaz a 4 kapszula összetétele összehasonlítva az AREDS formulával: / C-vitamin 500 mg / E-vitamin 400 IU / cink (oxid) 80 mg / réz (citrát) 2 mg / béta-karotin 7,5 mg / lutein 6 mg Hamarosan kapható az AREDS 2 tanulmány szerinti formula! ЕВВЕЕЕШб Speciális - gyógy. makulad betegek er^-

Next

/
  • Layout
  • Zoom
  • Rotation
Thumbnails
Contents